Targeting PIK3CA mutant breast cancer with the combination of PIK3CA-specific inhibitor, BYL719, and IGF1-R antibody, ganitumab

被引：0
|
作者：
Cao, Z. Alexander [1 ]
Pinzon-Ortiz, Maria [1 ]
Chen, Yan [1 ]
Li, Xiaoyan [1 ]
Beltran, Pedro J. [2 ]
Gansert, Jennifer [2 ]
Peters, Malte [3 ]
Schlegel, Robert [1 ]
Schumacher, Karl M. [3 ]
Huang, Alan [1 ]
机构：
[1] Novartis, Cambridge, MA USA
[2] Amgen Inc, Thousand Oaks, CA USA
[3] Novartis, Basel, Switzerland
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3683
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3683
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PIK3CA mutations in breast cancer: A potential predictive marker
    Santarpia, M.
    Rosell, R.
    Margeli, M.
    Mesiti, M.
    Cavallari, V
    Pitini, V
    Cirauqui, B.
    Reguart, N.
    Barnadas, A.
    Taron, M.
    Altavilla, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI36 - XI36
  • [42] PIK3CA mutations in breast cancer are associated with poor outcome
    Shao Ying Li
    Minna Rong
    Fabienne Grieu
    Barry Iacopetta
    Breast Cancer Research and Treatment, 2006, 96 : 91 - 95
  • [43] New Routes to Old Places: PIK3R1 and PIK3R2 Join PIK3CA and PTEN as Endometrial Cancer Genes
    Herrero-Gonzalez, Sandra
    Di Cristofano, Antonio
    CANCER DISCOVERY, 2011, 1 (02) : 106 - 107
  • [44] Frequency and spectrum of PIK3CA somatic mutations in breast cancer
    Martinez-Saez, Olga
    Chic, Nuria
    Pascual, Tomas
    Adamo, Barbara
    Vidal, Maria
    Gonzalez-Farre, Blanca
    Sanfeliu, Esther
    Schettini, Francesco
    Conte, Benedetta
    Braso-Maristany, Fara
    Rodriguez, Adela
    Martinez, Debora
    Galvan, Patricia
    Rodriguez, Ana Belen
    Martinez, Antonio
    Munoz, Montserrat
    Prat, Aleix
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [45] Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer
    Cardinali, Barbara
    De Luca, Giuseppa
    Tasso, Roberta
    Coco, Simona
    Garuti, Anna
    Buzzatti, Giulia
    Sciutto, Andrea
    Arecco, Luca
    Villa, Federico
    Carli, Franca
    Reverberi, Daniele
    Quarto, Rodolfo
    Dono, Mariella
    Del Mastro, Lucia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [46] Somatic mutations of PIK3CA and AKT1 in Japanese breast cancer
    Shimoi, T.
    Hamada, A.
    Kitamura, Y.
    Nishijo, T.
    Shimomura, A.
    Shimizu, C.
    Yoshida, M.
    Kinoshita, T.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [47] PIK3CA and AKT1 mutations are independent in invasive breast cancer
    Moynahan, M. E.
    Heguy, A.
    Drobnjak, M.
    Traina, T.
    Howard, J.
    Patil, S.
    Gerald, W.
    Solit, D.
    Hudis, C.
    CANCER RESEARCH, 2009, 69 (02) : 119S - 120S
  • [48] PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
    Loi, Sherene
    Michiels, Stefan
    Baselga, Jose
    Bartlett, John M. S.
    Singhal, Sandeep K.
    Sabine, Vicky S.
    Sims, Andrew H.
    Sahmoud, Tarek
    Dixon, J. Michael
    Piccart, Martine J.
    Sotiriou, Christos
    PLOS ONE, 2013, 8 (01):
  • [49] PIK3CA mutant allele differential expression (MADE) associates with breast cancer clinical features
    Xavier, J.
    Almeida, B.
    Sun, C.
    Silva, J.
    Marreiros, A.
    Eldridge, M.
    Bernards, R.
    Carlos, C.
    Chin, S. F.
    Maia, A. T.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S205 - S205
  • [50] PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis
    Mohammed A. Aleskandarany
    Emad A. Rakha
    Mohamed A. H. Ahmed
    Desmond G. Powe
    Emma C. Paish
    R. Douglas Macmillan
    Ian O. Ellis
    Andrew R. Green
    Breast Cancer Research and Treatment, 2010, 122 : 45 - 53
12345